Related Experiment Video
Updated: May 27, 2026

05:21
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Revisiting the influenza vaccine
Stephan L Foster1, Christine R Nevin-Woods
1University of Tennessee Health Science Center, 910 Madison St, Suite 324, Memphis, TN 38103-3454, USA. sfoster@uthsc.edu
The Journal of the American Osteopathic Association
|November 17, 2011
Summary
Influenza vaccination remains critical for public health, despite its proven success in preventing diseases. Patient education is key to increasing influenza vaccine uptake, especially among high-risk groups.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- Vaccination is a leading public health achievement, significantly reducing preventable diseases.
- Annual influenza epidemics in the US cause substantial morbidity and mortality.
- Low influenza vaccination rates persist, particularly in high-risk populations.
Purpose of the Study:
- To highlight the importance of influenza vaccination.
- To address the issue of low vaccination rates in the US.
- To emphasize the need for increased patient education on influenza vaccines.
Main Methods:
- Review of Centers for Disease Control and Prevention (CDC) data and recommendations.
- Analysis of current influenza vaccination trends and their impact.
- Assessment of public health strategies to improve vaccine uptake.
Main Results:
- Influenza continues to cause significant illness and death annually.
- A considerable segment of the population remains unvaccinated against influenza.
- Current recommendations include all individuals over six months for influenza vaccination.
Conclusions:
- Influenza vaccination is essential for mitigating disease burden.
- Patient education is a crucial strategy to enhance influenza vaccine acceptance.
- Broadened recommendations aim to protect all age groups, especially the vulnerable.
Related Concept Videos
Vaccinations
Overview
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cross-reactivity
Overview

